Hap Trading, LLC Allakos Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $14,560 - $34,384	-5,600 Reduced 15.47%	30,600 $1,000
Q1 2022 May 12, 2022	BUY	$5.08 - $9.81 $76,200 - $147,150	15,000 Added 70.75%	36,200 $12,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $181,260 - $2.37 Million	21,200 New	21,200 $18,000
Q1 2020 May 08, 2020	SELL	$44.49 - $93.39 $2.68 Million - $5.62 Million	-60,200 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$66.49 - $137.73 $4.65 Million - $9.63 Million	-69,900 Reduced 53.73%	60,200 $288,000
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $4.03 Million - $11.7 Million	130,100 New	130,100 $3.39 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $21.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.